Samuel J. Reich - 16 Mar 2022 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Executive Chairman, Director
Signature
/s/ Samuel J. Reich
Issuer symbol
SABS
Transactions as of
16 Mar 2022
Net transactions value
$0
Form type
4
Filing time
18 Mar 2022, 21:15:39 UTC
Previous filing
19 Nov 2021
Next filing
23 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Employee Stock Option (right to buy) Award $0 +7,000 $0.000000 7,000 16 Mar 2022 Common Stock 7,000 $1.78 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
F2 The shares underlying the option will vest in full on the one-year anniversary of March 16, 2022, the date the award was approved by the Company's board of directors.